Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer

This study has been completed.
Sponsor:
Collaborator:
BioCancell Ltd.
Information provided by:
Hebrew University of Jerusalem
ClinicalTrials.gov Identifier:
NCT00393809
First received: October 26, 2006
Last updated: December 25, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)